FDA Authorizes First Wearable Device to Track Both Ketones and Blood Sugar

The FDA has approved a groundbreaking wearable device that simultaneously monitors blood glucose and ketone levels, allowing people with diabetes to receive early warning signs of diabetic ketoacidosis (DKA), a life-threatening complication. This dual-tracking technology represents a major advancement in diabetes management, as it enables patients to detect dangerous metabolic changes before they become critical. The device provides continuous monitoring without requiring frequent finger sticks, improving quality of life while enhancing safety. This innovation is particularly valuable for individuals with type 1 diabetes and those at higher risk for DKA, offering proactive health management capabilities.